Xiaoyan Wu

901 total citations
49 papers, 527 citations indexed

About

Xiaoyan Wu is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Xiaoyan Wu has authored 49 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 11 papers in Immunology and 9 papers in Oncology. Recurrent topics in Xiaoyan Wu's work include Immune Cell Function and Interaction (6 papers), Viral-associated cancers and disorders (5 papers) and Autoimmune and Inflammatory Disorders Research (4 papers). Xiaoyan Wu is often cited by papers focused on Immune Cell Function and Interaction (6 papers), Viral-associated cancers and disorders (5 papers) and Autoimmune and Inflammatory Disorders Research (4 papers). Xiaoyan Wu collaborates with scholars based in China, United States and Spain. Xiaoyan Wu's co-authors include Runming Jin, Ke Lu, Hongbo Chen, Yuejia Luo, Pengfei Xu, Lian Duan, Ziping Zhao, Brian W. P. Seymour, Douglas S. Robinson and Maureen Howard and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, Brain Research and Journal of Controlled Release.

In The Last Decade

Xiaoyan Wu

43 papers receiving 522 citations

Peers

Xiaoyan Wu
Comparison fields: 5 of 105
  • Molecular Biology 150
  • Immunology 126
  • Physiology 89
  • Oncology 66
  • Hematology 61
Mohsen Saeidi Iran
Nobunao Ikewaki Japan
Jiang Zhang China
Anne Sailer United States
Mykolas Mauricas Lithuania
Xing Yang China
Valentina Zanin Italy
Stefanie Dichtl Austria
Eric B. Nonnecke United States
Gholam Ali Kardar Iran
Mohsen Saeidi Iran View profile →
Citations per field, relative to Xiaoyan Wu
Xiaoyan Wu · 1×
Citations per year, relative to Xiaoyan Wu
Xiaoyan Wu · 1×

Countries citing papers authored by Xiaoyan Wu

Since Specialization
Citations

This map shows the geographic impact of Xiaoyan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyan Wu more than expected).

Fields of papers citing papers by Xiaoyan Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyan Wu. The network helps show where Xiaoyan Wu may publish in the future.

Co-authorship network of co-authors of Xiaoyan Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyan Wu. A scholar is included among the top collaborators of Xiaoyan Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyan Wu. Xiaoyan Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Clinical analysis and case series report on autoimmune glial fibrillary acidic protein astrocytopathy presenting with autonomic dysfunction Frontiers in Neurology Xiaoyan Wu, Jin Zhang et al. 2
2 Uncovering key markers and therapeutic targets for renal fibrosis in diabetic kidney disease through bulk and single-cell RNA sequencing Journal of Translational Medicine Lijuan Li, Tao Mi et al. 1
3 Aculeapyridones A-Q, Pyranopyridone Alkaloids with Protective Effects against Acetaminophen-Induced Acute Liver Injury Discovered from a Coculture of Aspergillus aculeatinus WHUF0198 and a Penicillium sp. Journal of Natural Products Jun Wu, Mu Li et al. 2
4 Additional Insertion of gC Gene Triggers Better Immune Efficacy of TK/gI/gE-Deleted Pseudorabies Virus in Mice Viruses Meijing Chen, Xiaoyan Wu et al. 1
5 Efficacy and safety of recombinant human thrombopoietin for the treatment of chronic primary immune thrombocytopenia in children and adolescents: A multicentre, randomized, double‐blind, placebo‐controlled phase III trial British Journal of Haematology Xiaoli Zhang, Libo Zhao et al. 1
6 Clinical significance and different strategies for re-elevation of plasma EBV-DNA during treatment in pediatric EBV-associated hemophagocytic lymphohistiocytosis Jornal de Pediatria Lizhen Zhao, Xiaoyan Wu et al. 1
7 Morphology-based deep learning enables accurate detection of senescence in mesenchymal stem cell cultures BMC Biology Mingzhu Li, Xiaoyan Wu et al. 18
8 Suv39h1 contributes to activation of hepatic stellate cells in non-alcoholic fatty liver disease by enabling anaerobic glycolysis Life Sciences Xiaoyan Wu, Yuzhou Shen et al. 8
9 Gut microbiota contributes to the methionine metabolism in host Frontiers in Microbiology Xiaoyan Wu, Ziyi Han et al. 24
10 Confirmation value of Western blotting in detecting anti-treponema pallidum specific antibodies with suspicious results European journal of medical research Siqi Xu, Hongsheng Li et al. 0
11 Qishen Yiqi dropping pills improve isoproterenol-induced cardiomyocyte hypertrophy by regulating X-inactive specific transcript (XIST) expression in rats Journal of Thoracic Disease Ying Luo, Jiaxian Chen et al. 2
12 Probiotics in Cancer Frontiers in Oncology Ke Lu, Xiaoyan Wu et al. 80
13 High-Dose Methotrexate-Induced Idiopathic Intracranial Hypertension in Infant Acute Lymphoblastic Leukemia Frontiers in Pharmacology Zhu‐Jun Wang, Ran Wang et al. 0
14 <p>Construction of Nomograms for Predicting Pathological Complete Response and Tumor Shrinkage Size in Breast Cancer</p> Cancer Management and Research Shuai Yan, Wenjie Wang et al. 16
15 Rare Presentation of Pseudotumor Cerebri in a Pediatric Patient With Granulomatosis With Polyangiitis Cureus Xiaoyan Wu, Rabheh Abdul‐Aziz et al. 1
16 Microarray analysis of an synthetic α-synuclein induced cellular model reveals the expression profile of long non-coding RNA in Parkinson’s disease Brain Research Xiangfeng Jing, Yang Chen et al. 26
17 Bone-targeting nanoparticle to co-deliver decitabine and arsenic trioxide for effective therapy of myelodysplastic syndrome with low systemic toxicity Journal of Controlled Release Xiaoyan Wu, Zhenhua Hu et al. 32
18 SAT0252 The number of treg cells in peripheral blood in pss patients is decreased and low dose IL-2 can promote its proliferation Annals of the Rheumatic Diseases Mingsan Miao, Yijia Guo et al. 0
19 Effective Concentration of a Multikinase Inhibitor within Bone Marrow Correlates with In Vitro Cell Killing in Therapy-Resistant Chronic Myeloid Leukemia Molecular Cancer Therapeutics Chaofeng Mu, Xiaoyan Wu et al. 5
20 Severe Hemorrhage in Chinese Children With Immune Thrombocytopenia Journal of Pediatric Hematology/Oncology Fen Zhou, Yunyun Xu et al. 9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026